Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Royalindo Investa Wijaya Tbk. (INDO) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Royalindo Investa Wijaya Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Royalindo Investa Wijaya Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Royalindo Investa Wijaya Tbk. trades at Rp184 (market cap 819.98B, 35.04M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume). The key difference: Royalindo Investa Wijaya Tbk. is the larger of the two by market cap, and Royalindo Investa Wijaya Tbk. is more actively traded (35.04M versus 635.5K). Which is the better fit depends on your goals.

INDOLABS
Market Cap
819.98B691.25B
Volume
35.04M635.5K
Lot
350.41K6.36K
Turnover
6.39B110.15M
Average Price
182.46173.33
Value
6.39B110.15M
Indicative Equilibrium Price
184174
Indicative Equilibrium Volume
1550

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INDO
View details
LABS
View details

About Royalindo Investa Wijaya Tbk.

PT Royalindo Investa Wijaya Tbk (the Company) was established based on Notarial Deed No. 19 dated July 6, 2005 of Tse Min Suhardi, S.H., a public notary in Jakarta. The Company started its commercial operations in July 6, 2005.

Read more on INDO

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS